Bergstrom, J.D., Bostedor, R.G., Masarachia, P.J., Reszka, A.A. and Rodan, G. (2000) Alendronate Is a Specific, Nanomolar Inhibitor of Farnesyl Diphosphate Synthase. Archives of Biochemistry and Biophysics, 373, 231-241.
https://doi.org/10.1006/abbi.1999.1502

has been cited by the following article:

• TITLE: Bisphosphonates Zoledronate and Alendronate for the Management of Postmenopausal Osteoporosis

  AUTHORS: IsraaIsraa Ahmed Radwan, Nahed Sedky Korany, Bassant Adel Ezzat

  KEYWORDS: Bisphosphonates, Alendronate, Zoledronate, Postmenopausal Osteoporosis

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.7 No.5, May 10, 2018

  ABSTRACT: Bisphosphonates are among the most frequently used antiresorptive drugs for the management of postmenopausal osteoporosis. We review here two of the commonly used bisphosphonates zoledronate and alendronate.